New Drug Approvals Archive

Get news by email or subscribe to our news feeds.

March 2004

March 1

Iquix (levofloxacin ophthalmic) Ophthalmic Solution

Date of Approval: March 1, 2004
Company: Santen
Treatment for: Corneal Ulcers

Iquix (levofloxacin) is a topical fluoroquinolone indicated for the treatment of bacterial corneal ulcers.

Iquix (levofloxacin ophthalmic) FDA Approval History

March 8

Sensipar (cinacalcet) Tablets

Date of Approval: March 8, 2004
Company: Amgen Inc.
Treatment for: Secondary Hyperparathyroidism, Hypercalcemia of Malignancy

Sensipar (cinacalcet) is a calcimimetic agent indicated for the treatment of secondary hyperparathyroidism in dialysis patients and for the treatment of hypercalcemia in patients with parathyroid carcinoma.

Sensipar (cinacalcet) FDA Approval History

March 24

Follistim AQ (follitropin beta) Injection

Date of Approval: March 24, 2004
Company: Organon USA Inc.
Treatment for: Ovulation Induction, Female Infertility, Hypogonadism -- Male

Follistim AQ (follitropin beta) is human follicle-stimulating hormone prescribed for women undergoing assisted reproductive treatments (ART) such as in vitro fertilization (IVF), and for the induction of ovulation to achieve pregnancy, and for men with hypogonadism.

Follistim AQ (follitropin beta) FDA Approval History

March 30

Zyprexa (olanzapine)

New Dosage Form Approved: March 29, 2004

Hide
(web4)